Gradual Egg-tolerance Induction in Hen's Egg Allergic Children
Launched by DOMINQUE BULLENS · Jun 29, 2015
Trial Information
Current as of May 30, 2025
Unknown status
Keywords
ClinConnect Summary
1. The investigators here want to test the hypothesis that a total period of 18 months of gradual open introduction of a certain egg product with regard to full egg tolerance induction is not inferior when compared to a total period of 30 months gradual open introduction of a certain egg product (see steps for the specific egg products) after tolerance to baked egg has been obtained.
2. The investigators also want to define step-specific 'tolerance-failures' and study the relevance of specific IgE to specific egg components to predict failures at each step.
Step 1: open baked egg test pass...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children (1-18y) had or have a clinical diagnosis of IgE mediated hen's egg allergy based on positive history as well as skin prick testing and/or specific IgE detection by CAPtest in an allergy clinic
- • 2. Children are at least 12 months old before introduction of heated egg is considered
- • 3. Children did not suffer from a moderate-to-severe anaphylaxis due to egg-ingestion at presentation
- • 4. Children have specific IgE levels to Gal d 1 below 1.2 kU/mL or passed cake provocation test -
- Exclusion Criteria:
- • 1. Children had a moderate-to severe anaphylaxis due to egg ingestion
- • 2. Children are younger than 12 months old at the moment of passing heated egg open provocation test
- • 3. Parents are not able or not willing to test a certain step in the tolerance induction at home -
About Dominque Bullens
Dominique Bullens is an esteemed clinical trial sponsor dedicated to advancing medical research through innovative study designs and robust trial management. With a focus on enhancing patient outcomes, the organization collaborates with a network of healthcare professionals and research institutions to conduct high-quality clinical trials across various therapeutic areas. Committed to ethical standards and regulatory compliance, Dominique Bullens leverages cutting-edge technology and data analytics to ensure the integrity and efficiency of its trials, ultimately contributing to the development of safe and effective medical interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, Vlaams Brabant, Belgium
Hasselt, , Belgium
Bonheiden, , Belgium
Brugge, , Belgium
Ghent, , Belgium
Oostende, , Belgium
Patients applied
Trial Officials
Dominique MA Bullens, MD, PhD
Principal Investigator
UZ Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials